Premium
The anticonvulsive activity and toxicity of diazepam in three different formulations. An experimental study in mice
Author(s) -
Högskilde S.,
Nielsen J. W.,
Carl P.,
Angelo H.,
Sörensen M. Bredgaard
Publication year - 1987
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/j.1399-6576.1987.tb02568.x
Subject(s) - diazepam , ed50 , medicine , toxicity , pharmacology , median lethal dose , acute toxicity , drug , anesthesia , therapeutic index , anticonvulsant , neurotoxicity , epilepsy , receptor , psychiatry
The anticonvulsive activity (ED50), acute toxicity (LD50), and minimal neurotoxicity (TD50) of diazepam in an emulsion form (Diazemuls®) were compared with two different water‐based diazepam solutions (Valium® and Stesolid®). The diazepam preparations were administered intravenously to male mice. After determination of time of peak drug activity, the ED50's were established against pentetrazol‐induced convulsions, at peak drug activity. The most important difference between the three diazepam preparations was a significantly higher LD50 of diazemuls (275 mg/kg) compared to Valium (49 mg/kg) and stesolid (51 mg/kg). ED50 was: diazemuls 0.24 mg/kg, Valium 0.14 mg/kg and stesolid 0.10 mg/kg. The therapeutic indices (LD50/ED50) were thus calculated to he 1146 for diazemuls, 350 for Valium and 510 for stesolid. Time of peak drug activity and TD50 were equal for all three drugs. No signs of pain on injection or necrosis were observed following diazemuls, whereas this was common after Valium and stesolid.